Nocturnal Vasomotor Events as a Digital Biomarker
Hot flushes are counted by asking people to remember them, including the ones that happened while they were asleep. Skin conductance counts them instead.
Evidence maturity
Graded with the V3 framework: whether the sensor measures accurately, whether the algorithm has been validated against a reference standard, and whether the measure has been shown to matter clinically.
Objective skin conductance measurement has a research literature going back decades and a documented divergence from self report, with physiologically assessed events linked to endothelial function. Wrist based alternatives are less validated and no measure holds an endpoint qualification.
What are Nocturnal Vasomotor Events
Vasomotor symptoms, commonly called hot flushes and night sweats, are the defining symptom of the menopause transition. A nocturnal vasomotor event is one occurring during sleep, detected objectively rather than reported.
The measurement case is the same as for nocturnal scratch: the events happen while the person is asleep, so morning recall is an estimate of something they were largely unconscious for. Studies comparing subjective and objective hot flash measures have found substantial divergence, with self report and physiological detection identifying overlapping but different sets of events.
The physiological basis is a sudden peripheral vasodilation and sweating episode, which produces a characteristic rise in skin conductance and a change in skin temperature. That signature is what makes automated detection possible, and it is why this measure sits at the intersection of women's health, sleep and the autonomic domain.
How it is measured
The established objective method is sternal skin conductance monitoring, which detects the sweating response. Miniature ambulatory skin conductance monitors with dedicated event detection algorithms were developed specifically for hot flash research, and earlier work produced hygrometric recorders for the same purpose.
Contemporary approaches combine skin conductance with skin temperature and heart rate from wrist worn devices, which is more tolerable for multi night recording but has a weaker signal than a sternal electrode.
Detection thresholds are the design decision. Skin conductance rises with ambient heat, movement and arousal as well as with a vasomotor event, so algorithms trade sensitivity against false positives, and a night of restless sleep in a warm room generates plenty of both.
Clinical use
The main research use is as an outcome in trials of treatments for vasomotor symptoms, including hormone therapy and non hormonal alternatives, where the conventional endpoint is a symptom diary. Objective counting separates event frequency from event bother, which a diary conflates, and allows a treatment that reduces distress without reducing events to be distinguished from one that does the opposite.
The second use is mechanistic and cardiovascular. Physiologically assessed hot flashes have been associated with endothelial function in midlife women, which is a stronger form of evidence than self reported symptoms can support and is part of why objective measurement matters beyond symptom relief.
The third is the sleep link: nocturnal events fragment sleep, so pairing this measure with wake after sleep onset from the same night describes the symptom and its consequence together.
Regulatory status
No regulatory qualification as an endpoint. Symptom diaries remain the accepted outcome measure in vasomotor symptom trials.
Limitations
This measure has no instrument counterpart in this library at all. The menopause symptom scales that trials report alongside it, including the Greene Climacteric Scale and the Menopause Rating Scale, are not in the collection, which leaves the bridge empty and is recorded as a gap.
Objective and subjective counts diverge, and neither is straightforwardly the truth: a physiologically detected event the person slept through may matter less than one that woke them, so an objective count alone can misrepresent burden.
Sternal electrodes are not tolerable for long recordings, and wrist based alternatives have not been validated to the same standard. Ambient temperature is a first order confounder, and no wearable vasomotor measure currently holds a regulatory qualification as a trial endpoint.
References
- Thurston RC, et al. Physiologically assessed hot flashes and endothelial function among midlife women. Menopause. 2018. pubmed.ncbi.nlm.nih.gov
- Freedman RR. Menopausal hot flashes: mechanisms, endocrinology, treatment. J Steroid Biochem Mol Biol. 2014. pubmed.ncbi.nlm.nih.gov
- Bahr DE, et al. Miniature ambulatory skin conductance monitor and algorithm for investigating hot flash events. Physiol Meas. 2014. pubmed.ncbi.nlm.nih.gov
- Otte JL, et al. Comparison of subjective and objective hot flash measures over time among breast cancer survivors. Menopause. 2009. pubmed.ncbi.nlm.nih.gov
Menopause symptom scales such as the Greene Climacteric Scale and the Menopause Rating Scale are not in this library, so this measure has no counterpart here. Vasomotor symptoms are otherwise captured by patient diary, with the recall limits that implies.
Collect your digital biomarker data in no time all under your own brand
Collect meaningful digital biomarker data from your patients with ease. Our platform connects with wearables, smartphones, and other digital health devices, helping you capture continuous, real world data for research or clinical use all within your own branded experience.
Learn More.png){kind=icon}
Connect your Data Sources
.png)
.png){kind=icon}
Collect Data Continuously
.svg)
.svg)
.png){kind=icon}
Collect the Data that Matters
.svg)
.png){kind=icon}
Monitor the Full Patient Journey
.png)
.png)
%20(1).png)
.png)
evidence and commerclise
%20(1).png)
%20(1).png)
%20(1).png)
Rapidly design and configure complex studies in one place.
.avif)
Capture unified, multimodal data with automated workflows.
.svg)
.svg)
Evaluate clinical algorithms instantly with AI powered tools.
.svg)
.svg){kind=icon}
